Health-related quality of life in patients with systemic lupus erythematosus and its relationship with cyclophosphamide pulse therapy

Gilboe, 1999, Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls, J Rheumatol, 26, 1694 Perez-Cuevas, 1999, A quality of life study in women with systemic lupus erythematosus and its relation to disease activity, An Med Interna, 16, 457 Sutcliffe, 1999, Associates of health status in patients with SLE, J Rheumatol, 26, 2352 Alarcón, 2004, Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course, Arthritis Rheum, 51, 465, 10.1002/art.20409 Doria, 2004, Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants, Rheumatology, 43, 1580, 10.1093/rheumatology/keh392 Gladman, 1996, Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life, Clin Exp Rheumatol, 14, 305 Stoll, 1997, Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus, J Rheumatol, 24, 1608 Saba, 2003, Inverse correlation of each functional status scale of the SF-36 with degree of disease activity in systemic lupus erythematosus (m-SLAM), Jt Bone Spine, 70, 348, 10.1016/S1297-319X(03)00065-4 Rupert, 2004, Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage, Arthrtitis Rheum, 51, 458, 10.1002/art.20412 Greco, 2004, Effects of disease activity, pain, and distress on activity limitations in patients with systemic lupus erythematosus, J Rheumatol, 31, 260 Jolly, 2004, Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life?, Lupus, 13, 924, 10.1191/0961203304lu2034oa Appel, 1987, Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization, Am J Med, 83, 877, 10.1016/0002-9343(87)90645-0 Gourley, 1996, Methylprednisolone and cyclophosphamide alone or in combination in patients with lupus nephritis. A randomized controlled trial, An Intern Med, 125, 549, 10.7326/0003-4819-125-7-199610010-00003 Dooley, 1998, Immunosuppressive therapy of lupus nephritis, Lupus, 7, 630, 10.1191/096120398678920767 Takada, 2001, Cyclophosphamide for the treatment of lupus erythematosus systemic, Lupus, 10, 154, 10.1191/096120301671376017 Fraenkel, 2002, Patients preferences for treatment of lupus nephritis, Arthritis Rheum, 47, 421, 10.1002/art.10534 Tan, 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 25, 1271, 10.1002/art.1780251101 Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 1725, 10.1002/art.1780400928 Urowitz, 1984, The Lupus Activity Criteria Count (LACC), J Rheumatol, 11, 783 Ciconelli, 1999, Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36, Rev Bras Reumatol, 39, 143 Gladman, 1996, A comparison of five health status instruments in patients with systemic lupus erythematosus, Lupus, 5, 190, 10.1177/096120339600500305 Ware, 1994 Ware, 1995, Comparison of methods for the scoring and statistical analysis of SF-36 Health Profile and summary measures: summary of results from the Medical Outcomes Study, Med Care, 33, AS264 Mari, 1985, A comparison of the validity of two psychiatric screening questionnaires (GHQ-12 and SRQ-20) in Brazil, using relative operating characteristic (ROC) analysis, Psychol Med, 15, 651, 10.1017/S0033291700031500 StataCorp Stata Statistical Software: release 7.0. Stata Corporation, 2001. Gladman, 1996, Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in Systemic Lupus Erythematosus. Systemic Lupus International Collaborating Clinics Group, J Rheumatol, 23, 1953 Freire, 2007, Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil, Clin Rheum, 26, 423, 10.1007/s10067-006-0517-6 Ferraz, 2001 Meinão, 2001 D´Amorim, 2001 Vu, 1999, A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease, J Rheumatol, 26, 2595 Wang, 2001, The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus, J Rheumatol, 28, 525 Bae, 2001, Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus, J Rheumatol, 28, 1245 Karlson, 1997, The relationship of socioeconomic status, race and modifiable risk factors to outcomes in patients with systemic lupus erythematosus, Arthritis Rheum, 40, 47, 10.1002/art.1780400108 Panopalis, 2005, The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being, Rheumatology, 44, 751, 10.1093/rheumatology/keh580 Rood, 2000, Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy, J Rheumatol, 27, 2057 Fortin, 1998, Impact of disease activity and cumulative damage on the health of lupus patients, Lupus, 7, 101, 10.1191/096120398678919813